Cancer Therapy: Clinical Cross-StratificationandDifferential RiskbyBreast Cancer Index and Recurrence Score in Women with Hormone Receptor–Positive Lymph Node– Negative Early-Stage Breast Cancer
نویسندگان
چکیده
Purpose: Previous results from the TransATAC study demonstrated that both the Breast Cancer Index (BCI) and the OncotypeDX Recurrence Score (RS) added significant prognostic information to clinicopathologic factors over a 10-year period. Here, we examined cross-stratification between BCI and RS to directly compare their prognostic accuracy at the individual patient level. Experimental Design: A total of 665 patients with hormone receptor–positive (HRþ) and lymph node–negative disease were included in this retrospective analysis. BCI andRS risk groupswere determined using predefined clinical cut-off points. Kaplan– Meier estimates of 10-year risk of distant recurrence (DR) and log-rank tests were used to examine cross-stratification between BCI and RS. Results: As previously reported, both RS and BCI were significantly prognostic in years 0 to 10. BCI provided significant additional prognostic information to theClinical Treatment Score (CTS) plus RS (DLR-c1⁄4 11.09; P < 0.001), whereas no additional prognostic information was provided by RS to CTS plus BCI (DLR-c 1⁄4 2.22; P 1⁄4 0.1). Restratification by BCI of the low and intermediate RS risk groups led to subgroups with significantly different DR rates (P < 0.001 and P 1⁄4 0.003, respectively). In contrast, restratified subgroups created by RS of BCI risk groups did not differ significantly. Conclusions: In this retrospective analysis, BCI demonstrated increased prognostic accuracy versus RS. Notably, BCI identified subsets of RS low and RS intermediate risk patients with significant and clinically relevant rates of DR. These results indicate that additional subsets of women with HRþ, lymph node–negative breast cancer identified by BCI may be suitable candidates for adjuvant chemotherapy or extended endocrine therapy. Clin Cancer Res; 22(20); 5043–8. 2016 AACR. See related commentary by Brufsky and Davidson, p. 4963
منابع مشابه
Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer.
PURPOSE Previous results from the TransATAC study demonstrated that both the Breast Cancer Index (BCI) and the OncotypeDX Recurrence Score (RS) added significant prognostic information to clinicopathologic factors over a 10-year period. Here, we examined cross-stratification between BCI and RS to directly compare their prognostic accuracy at the individual patient level. EXPERIMENTAL DESIGN A...
متن کاملCorrelation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors
Background and Objective: Breast cancer is the commonest cancer of Indian women. Estrogen and Progesterone expression is seen in benign breast lesions and in breast carcinoma associated with good prognostic parameters and it correlates well with response to hormone therapy. Although a lot of studies have been conducted in the past on hormone receptor expression in breast cancer and few have cor...
متن کاملAssociation Between Oncotype DX Recurrence Score and Clinicopathological Variables in Breast Cancer Patients
Introduction: Breast cancer is the most common cancer and the leading cause of cancer-related death in women. Clinicopathological variables are important factors in deciding on breast cancer treatment. This study evaluated the association between the recurrence score generated by the Oncotype DX® 21-gene assay and classic clinicopathological variables. Methods: A single-institution retrospect...
متن کاملبررسی فراوانی حضور مارکر ایمونوهیستوشیمی فروپورتین در نمونههای بهدستآمده از بافت سرطانی بیماران مبتلا به سرطان پستان و ارتباط آن با فاکتورهای پروگنوستیک
Background & Aims: Breast cancer is the most prevalent malignancy in women. A few articles describe a marked decrease in the levels of ferroportin in breast cancer cells.The presented results demonstrate convincingly the incredible diagnostic and prognostic value of ferroportin expression in breast cancer and suggest that determination of this molecular marker maybe used as guidance toward ind...
متن کاملEffect of hormone receptors and Her-2 status on metastasis status in patients with breast cancer using logistic regression model
Introduction: Breast cancer is the most common type of cancer and the leading cause of cancer death among women. According to estimates in 2018, the most frequency of cancer in Iranian women was related to breast cancer with 13776 (12.5%) new cases. Metastasis is a complication of this disease that occurs in 1%-5% of patients. The aim of this study was to investigate the effect of hormone recep...
متن کامل